KALA BIO, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
KALA BIO, INC. (KALA) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.10% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-04-15
- KALA BIO, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was 0.10%.
- KALA BIO, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.30%.
- KALA BIO, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -15.30%.
- KALA BIO, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.50%, a 183.33% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.10% 10-K · filed 2026-04-15 | |
| 2024-12-31 | -0.30% 10-K · filed 2026-04-15 | -26.30% 10-K · filed 2025-03-31 |
| 2023-12-31 | -15.30% 10-K · filed 2025-03-31 | -0.70% 10-K · filed 2024-03-29 |
| 2022-12-31 | -0.50% 10-K · filed 2024-03-29 | |
| 2021-12-31 | 0.60% 10-K · filed 2023-03-03 | |
| 2020-12-31 | -0.90% 10-K · filed 2021-02-25 | |
| 2019-12-31 | -0.50% 10-K · filed 2021-02-25 | |
| 2018-12-31 | -1.10% 10-K · filed 2020-02-12 | -6.60% 10-K · filed 2019-03-12 |
| 2017-12-31 | -3.10% 10-K · filed 2019-03-12 | |
| 2016-12-31 | -0.50% 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |